The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders

British Journal of Haematology

Volumn 136, Issue 5, 2007, Pages 745-751

  Larsen, Thomas Stauffer ^a   Christensen, Jacob Haaber ^a   Hasselbalch, Hans Carl ^a   Pallisgaard, Niels ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Clonality; Fluorescence activated cell sorted; Mutation analysis; Myeloproliferative; Real time quantitative PCR

Indexed keywords

JANUS KINASE 2;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOID CELL; MALE; MUTATIONAL ANALYSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PHILADELPHIA CHROMOSOME NEGATIVE CELL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; T LYMPHOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

AGED; B-LYMPHOCYTES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; PHILADELPHIA CHROMOSOME; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 33846976182     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06497.x     Document Type: Article

References (30)

1. Adamson, J.W., Fialkow, P.J., Murphy, S., Prchal, J.F. & Steinmann, L. (1976) Polycythemia vera: stem-cell and probable clonal origin of the disease. New England Journal of Medicine, 295, 913-916.
2. Anger, B., Janssen, J.W., Schrezenmeier, H., Hehlmann, R., Heimpel, H. & Bartram, C.R. (1990) Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia, 4, 258-261.
3. Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. & Green, A.R. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054-1061.
4. Buschle, M., Janssen, J.W., Drexler, H., Lyons, J., Anger, B. & Bartram, C.R. (1988) Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation. Leukemia, 2, 658-660.
5. Campbell, P.J., Scott, L.M., Buck, G., Wheatley, K., East, C.L., Marsden, J.T., Duffy, A., Boyd, E.M., Bench, A.J., Scott, M.A., Vassiliou, G.S., Milligan, D.W., Smith, S.R., Erber, W.N., Bareford, D., Wilkins, B.S., Reilly, J.T., Harrison, C.N. & Green, A.R. (2005) Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet, 366, 1945-1953.
6. Casadevall, N., Vainchenker, W., Lacombe, C., Vinci, G., Chapman, J., Breton-Gorius, J. & Varet, B. (1982) Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. Blood, 59, 447-451.
7. Delhommeau, F., Dupont, S., Tonetti, C., Masse, A., Godin, I., Le Couedic, J.P., Debili, N., Saulnier, P., Casadevall, N., Vainchenker, W. & Giraudier, S. (2006) Evidence that the JAK2 G1849T (V617F) mutation occurs in a lympho-myeloid progenitor in polycythemia vera and idiopathic myelofibrosis. Blood, 109, 71-77.
8. el-Kassar, N., Hetet, G., Briere, J. & Grandchamp, B. (1997) Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood, 89, 128-134.
9. Fialkow, P.J., Denman, A.M., Jacobson, R.J. & Lowenthal, M.N. (1978) Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. Journal of Clinical Investigation, 62, 815-823.
10. Fialkow, P.J., Faguet, G.B., Jacobson, R.J., Vaidya, K. & Murphy, S. (1981) Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood, 58, 916-919.
11. Gilliland, D.G., Blanchard, K.L., Levy, J., Perrin, S. & Bunn, H.F. (1991) Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proceedings of the National Academy of Sciences of the United States of America, 88, 6848-6852.
12. Hou, Y.H., Srour, E.F., Ramsey, H., Dahl, R., Broxmeyer, H.E. & Hromas, R. (2005) Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood, 105, 3488-3492.
13. Ishii, T., Bruno, E., Hoffman, R. & Xu, M. (2006) Involvement of various hematopoietic cell lineages by the JAK2V617F mutation in polycythemia vera. Blood, 108, 3128-3134.
14. Jacobson, R.J., Salo, A. & Fialkow, P.J. (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood, 51, 189-194.
15. James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., Naceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N. & Vainchenker, W. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 1144-1148.
16. Katsura, Y. (2002) Redefinition of lymphoid progenitors. Nature Reviews Immunology, 2, 127-132.
17. Kralovics, R., Guan, Y. & Prchal, J.T. (2002) Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Experimental Hematology, 30, 229-236.
18. Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. & Skoda, R.C. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, 352, 1779-1790.
19. Kralovics, R., Teo, S.S., Li, S., Theocharides, A., Buser, A.S., Tichelli, A. & Skoda, R.C. (2006) Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood, 108, 1377-1380.
20. Lacout, C., Pisani, D.F., Tulliez, M., Gachelin, F.M., Vainchenker, W. & Villeval, J.L. (2006) JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood, 108, 1652-1660.
21. Lasho, T.L., Mesa, R., Gilliland, D.G. & Tefferi, A. (2005) Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes. British Journal of Haematology, 130, 797-799.
22. Levine, R.L., Wadleigh, M., Cools, J., Ebert, B.L., Wernig, G., Huntly, B.J., Boggon, T.J., Wlodarska, I., Clark, J.J., Moore, S., Adelsperger, J., Koo, S., Lee, J.C., Gabriel, S., Mercher, T., D'Andrea, A., Frohling, S., Dohner, K., Marynen, P., Vandenberghe, P., Mesa, R.A., Tefferi, A., Griffin, J.D., Eck, M.J., Sellers, W.R., Meyerson, M., Golub, T.R., Lee, S.J. & Gilliland, D.G. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387-397.
23. Martin, P.J., Najfeld, V., Hansen, J.A., Penfold, G.K., Jacobson, R.J. & Fialkow, P.J. (1980) Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature, 287, 49-50.
24. Raskind, W.H., Jacobson, R., Murphy, S., Adamson, J.W. & Fialkow, P.J. (1985) Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia. Journal of Clinical Investigation, 75, 1388-1390.
25. Reeder, T.L., Bailey, R.J., Dewald, G.W. & Tefferi, A. (2003) Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. Blood, 101, 1981-1983.
26. Schwarz, B.A. & Bhandoola, A. (2006) Trafficking from the bone marrow to the thymus: a prerequisite for thymopoiesis. Immunological Reviews, 209, 47-57.
27. Scott, L.M., Scott, M.A., Campbell, P.J. & Green, A.R. (2006) Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood, 108, 2435-2437.
28. Tsukamoto, N., Morita, K., Maehara, T., Okamoto, K., Sakai, H., Karasawa, M., Naruse, T. & Omine, M. (1994) Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. British Journal of Haematology, 86, 253-258.
29. Wernig, G., Mercher, T., Okabe, R., Levine, R.L., Lee, B.H. & Gilliland, D.G. (2006) Expression of Jak2V617F causes a polycythemia veralike disease with associated myelofibrosis in a murine bone marrow transplant model. Blood, 107, 4274-4281.
30. Wolanskyj, A.P., Lasho, T.L., Schwager, S.M., McClure, R.F., Wadleigh, M., Lee, S.J., Gilliland, D.G. & Tefferi, A. (2005) JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance. British Journal of Haematology, 131, 208-213.